Nyxoah S.A.

Nyxoah S.A.

NYXH

NASDAQHealthcareMedical - Specialties

أحدث البيانات المتاحة

‏1.36 US$

+‏0.01 US$ · ‎+0.74‎%‎

تحميل

NYXH نظرة عامة على الشركة

ملف الشركة

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.